Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D11 OTHER DERMATOLOGICAL PREPARATIONS
D11A OTHER DERMATOLOGICAL PREPARATIONS
D11AX Other dermatologicals
D11AX22 Ivermectin
D00804 Ivermectin (JAN/USP/INN) <JP/US>
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P02 ANTHELMINTICS
P02C ANTINEMATODAL AGENTS
P02CF Avermectines
P02CF01 Ivermectin
D00804 Ivermectin (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antiparasitics
Anthelmintics
Ivermectin
D00804 Ivermectin (JAN/USP/INN)
Dermatological Agents
Pediculicides/Scabicides
Ivermectin
D00804 Ivermectin (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
64 Parasitics (systemic)
642 Anthelmintics
6429 Others
D00804 Ivermectin (JAN/USP/INN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D00804 Ivermectin
Transporter substrate
DG01665 ABCB1 substrate
D00804 Ivermectin
Antimicrobials [BR:br08307]
Antiparasitics
Antinematodal agents
Avermectines
D00804 Ivermectin (JAN/USP/INN) <JP/US>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00804
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00804
Drug transporters
D00804
Rx-to-OTC switch list in the USA [br08315.html]
D00804